Canada Pension Plan Investment Board’s Cytokinetics CYTK Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$954K	Buy	+11,200	New	+$804K	﹤0.01%	1039
2026 Q1	–	Sell	-2,100	Closed	-$133K	–	1765
2025 Q4	$133K	Buy	+2,100	New	+$131K	﹤0.01%	1758
2022 Q4	–	Sell	-7,200	Closed	-$349K	–	1187
2022 Q3	$349K	Buy	+7,200	New	+$347K	﹤0.01%	994
2014 Q2	–	Sell	-4,592	Closed	-$44K	–	1242
2014 Q1	$44K	Buy	+4,592	New	+$41.5K	﹤0.01%	1156

Other funds holding CYTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's CYTK Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Cytokinetics (CYTK) in Q2 2026: 11,200 shares worth $954K. The stake represents ﹤0.01% of the portfolio and ranks #1039 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in CYTK as recently as Q4 2025.

Canada Pension Plan Investment Board first reported a position in CYTK in Q1 2014 and has held it in 4 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Canada Pension Plan Investment Board held 11,200 shares of Cytokinetics worth $954K as of Q2 2026.
Cytokinetics was a new Canada Pension Plan Investment Board position in Q2 2026.
Cytokinetics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1039 holding.
Canada Pension Plan Investment Board first reported a position in Cytokinetics in Q1 2014 and has held it in 4 quarters since.
482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.